Pfizer to co-promote Exact Sciences’ Cologuard

 Pfizer to co-promote Exact Sciences’ Cologuard

Pfizer to co-promote Exact Sciences’ Cologuard

Shots:
  • Pfizer signed a Co-promotion agreement for Exact Sciences Cologuard,first and only FDA-approved non-invasive stool DNA screening test for colorectal cancer(CRC)
  •  Pfizer will co-promote Cologuard with Exact from Q4’18, also share total profits and marketing costs equally, Exact will take care of all manufacturing and laboratory operations for Cologuard
  • Cologuard is a DNA screening test approved by FDA in Aug 2014, to screen adults, ≥50 years are at risk for CRC
Click here to read full press release/ article | Ref: Exact Sciences | Image:  PRNewswire

Vartika Singh

Vartika Singh is a content writer who loves to write research articles and reports at PharmaShots. She has in-depth knowledge of the life sciences industry including the Pharma and Biotech sectors. Any articles written by her can be contacted at connect@pharmashots.com.

Related post